[ad_1]
The main Fox Business Flash titles are here. Find out what clicks on FoxBusiness.com.
AstraZeneca Plc sold its 7.7% stake in Moderna Inc for more than $ 1 billion after the shares of the US biotech company skyrocketed following the breakthrough of its coronavirus vaccine, reported the Times.
| Teleprinter | security | Latest | Change | Change% |
|---|---|---|---|---|
| AZN | API ASTRAZENECA | 48.38 | -0.53 | -1.08% |
| RNAm | MODERNA, INC. | 154.81 | +6.43 | + 4.33% |
The report adds that it is not clear over what period UK company AstraZeneca sold its stake in Moderna.
AMID VACCINATION DELAYS, ASTRAZENECA MAY HAVE VIOLATED EU CONTRACT ON COVID-19 PLANS
AstraZeneca and Moderna did not immediately respond to requests for comment.
AstraZeneca Plc sold its 7.7% stake in Moderna Inc for more than $ 1 billion after the US biotech company’s shares skyrocketed following the breakthrough of its coronavirus vaccine. (Melissa Melvin / AP Images for Tyson Foods file)
AstraZeneca maintains its partnership with Moderna on other treatments for the disease and may sell its AstraZeneca / University of Oxford COVID-19 vaccine in the future if the virus becomes endemic, the report adds.
Moderna, whose vaccine is cleared for emergency use against COVID-19 in the United States, said last week it expected sales of $ 18.4 billion from its coronavirus vaccine this year.
[ad_2]
Source link